HDR brachytherapy decreases proliferation rate and cellular progression of a radioresistant human squamous cell carcinoma in vitro

References

• Blockhuys S, Vanhoecke B, Paelinck L, Bracke M, De Wagter C. 2009. Development of in vitro models for investigating spatially fractionated irradiation: physics and biological results. Phys Med Biol. 54:1565–1578.
   PubMed Web of Science ®Google Scholar
• Brenner DJ. 1997. Radiation biology in brachytherapy. J Surg Oncol. 65:66–70.
   PubMed Web of Science ®Google Scholar
• Carlson DJ, Stewart RD, Li XA, Jennings K, Wang JZ, Guerrero M. 2004. Comparison of in vitro and in vivo/ratios for prostate cancer. Phys Med Biol. 49:4477–4491.
   PubMed Web of Science ®Google Scholar
• Feofanova N, Geraldo JM, Andrade LMD. 2014. Radiation oncology in vitro: trends to improve radiotherapy through molecular targets. Biomed Res Int. 2014:1–13.
   Web of Science ®Google Scholar
• Fowler JF. 2001. Biological factors influencing optimum fractionation in radiation therapy. Acta Oncol. 40:712–717.
   PubMed Web of Science ®Google Scholar
• Fritz P, Weber KJ, Frank C, Flentje M. 1996. Differential effects of dose rate and superfractionation on survival and cell cycle of V79 cells from spheroid and monolayer culture. Radiother Oncol. 39:73–79.
   PubMed Web of Science ®Google Scholar
• Furuta M, Tsukiyama I, Kano Y. 1999. Uniformity of biological effect in high-dose rate stepping source brachytherapy: an in vitro study. Eur J Cancer. 35:782–786.
   PubMed Web of Science ®Google Scholar
• Ghorbani M, Salahshour F, Haghparast A, Moghaddas TA, Knaup C. 2014. Effect of tissue composition on dose distribution in brachytherapy with various photon emitting sources. J Contemp Brachytherapy. 6:54–67.
   PubMed Web of Science ®Google Scholar
• Grusch M, Polgar D, Gfatter S, Leuhuber K, Huettenbrenner S, Leisser C, Fuhrmann G, Kassie F, Steinkellner H, Smid K, et al. 2002. Maintenance of ATP favours apoptosis over necrosis triggered by benzamide riboside. Cell Death Differ. 9:169–178.
   PubMed Web of Science ®Google Scholar
• Hall E, Giaccia AJ. 2006. Radiobiology for the radiologist. 6th ed. McAllister L, editor. Philadelphia, PA: Lippincott Williams & Wilkins.
   Google Scholar
• Hedman M, Bjork-Eriksson T, Mercke C, West C, Hesselius P, Brodin O. 2009. Comparison of predicted and clinical response to radiotherapy: a radiobiology modelling study. Acta Oncol. 48:584–590.
   PubMed Web of Science ®Google Scholar
• Heuskin a-C, Michiels C, Lucas S. 2013. Toward computer simulation of high-LET in vitro survival curves. Phys Med Biol. 58:6495–6510.
   PubMed Web of Science ®Google Scholar
• Kiyozuka M, Akimoto T, Fukutome M, Motegi A, Mitsuhashi N. 2013. Radiation-induced dimer formation of EGFR: Implications for the radiosensitizing effect of cetuximab. Anticancer Res. 33:4337–4346.
   PubMed Web of Science ®Google Scholar
• Konijnenberg MW, Breeman WAP, de Blois E, Chan HS, Boerman OC, Laverman P, Kolenc-Peitl P, Melis M, de Jong M. 2014. Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amount. EJNMMI Res. 4:47.
   PubMed Web of Science ®Google Scholar
• Andrade LM, Geraldo JM. 2012. Nucleoplasmic calcium buffering sensitizes human squamous cell carcinoma to anticancer therapy. J Cancer Sci Ther. 4:131–139.
   Google Scholar
• Mazzeo E, Hehlgans S, Valentini V, Baumann M, Cordes N. 2012. The impact of cell-cell contact, E-cadherin and EGF receptor on the cellular radiosensitivity of A431 cancer cells. Radiat Res. 178:224–233.
   PubMed Web of Science ®Google Scholar
• Molnár J, Frank É, Minorics R, Kádár Z, Ocsovszki I, Schönecker B, Wölfling J, Zupkó I. 2015. A click approach to novel D-ring-substituted 16α-triazolylestrone derivatives and characterization of their antiproliferative properties. PLoS One. 10:1–28.
   Web of Science ®Google Scholar
• Morton GC, Hoskin PJ. 2013. Brachytherapy: current status and future strategies – can high dose rate replace low dose rate and external beam radiotherapy? Clin Oncol (R Coll Radiol). 25:474–482.
   PubMed Web of Science ®Google Scholar
• Nag S, Gupta N. 2000. A simple method of obtaining equivalent doses for use in HDR brachytherapy. Int J Radiat Oncol Biol Phys. 46:507–513.
   PubMed Web of Science ®Google Scholar
• Nag S, Scruggs GR. 2008. Clinical aspects and application of high-dose-rate brachytherapy. In: Halperin EC, Perez CA, Brady LW, editors. Perez and Brady’s: Principles and practice of radiation oncology. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; pp. 560–582.
   Google Scholar
• Ng CE, Keng PC, Sutherland RM. 1987. Characterization of radiation sensitivity of human squamous carcinoma A431 cells. Br J Cancer. 56:301–307.
   PubMed Web of Science ®Google Scholar
• Olsen DR. 1997. Implications of radiation induced apoptosis on calculated radial cell inactivation for a linear 192Ir source. Acta Oncol. 36:261–266.
   PubMed Web of Science ®Google Scholar
• Palmer A, Bradley D, Nisbet A. 2012. Physics-aspects of dose accuracy in high dose rate (HDR) brachytherapy: source dosimetry, treatment planning, equipment performance and in vivo verification techniques. J Contemp Brachytherapy. 4:81–91.
   PubMed Web of Science ®Google Scholar
• Petersen C, Zips D, Krause M, Schöne K, Eicheler W, Hoinkis C, Thames HD, Baumann M. 2001. Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation. Int J Radiat Oncol Biol Phys. 51:483–493.
   PubMed Web of Science ®Google Scholar
• Raffi JA, Davis SD, Hammer CG, Micka JA, Kunugi KA, Musgrove JE, Winston JW, Ricci-Ott TJ, DeWerd LA. 2010. Determination of exit skin dose for 192Ir intracavitary accelerated partial breast irradiation with thermoluminescent dosimeters. Med Phys. 37:2693–2702.
   PubMed Web of Science ®Google Scholar
• Rainey MD, Black EJ, Zachos G, Gillespie DAF. 2008. Chk2 is required for optimal mitotic delay in response to irradiation-induced DNA damage incurred in G2 phase. Oncogene. 27:896–906.
   PubMed Web of Science ®Google Scholar
• Saadat YR, Saeidi N, Vahed SZ, Barzegari A, Barar J. 2015. An update to DNA ladder assay for apoptosis detection. Bioimpacts. 5:25–28.
   PubMed Web of Science ®Google Scholar
• Stevens JB, Liu G, Bremer SW, Ye KJ, Xu W, Xu J, Sun Y, Gen SW, Savasan S, Krawetz SA, et al. 2007. Mitotic cell death by chromosome fragmentation. Cancer Res. 67:7686–7694.
   PubMed Web of Science ®Google Scholar
• Strigari L, Sciuto R, Rea S, Carpanese L, Pizzi G, Soriani A, Iaccarino G, Benassi M, Ettorre GM, Maini CL. 2010. Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR spheres: radiobiologic considerations. J Nucl Med. 51:1377–1385.
   PubMed Web of Science ®Google Scholar
• Tesei A, Sarnelli A, Arienti C, Menghi E, Medri L, Gabucci E, Pignatta S, Falconi M, Silvestrini R, Zoli W, et al. 2013. In vitro irradiation system for radiobiological experiments. Radiat Oncol. 8:257.
   PubMed Web of Science ®Google Scholar
• Versiani AF, Andrade LM, Martins EMN, Scalzo S, Geraldo JM, Chaves CR, Ferreira DC, Ladeira M, Guatimosim S, Ladeira LO, et al. 2016. Gold nanoparticles and their applications in biomedicine. Future Virol. 11:293–309.
   Web of Science ®Google Scholar
• Wang ZM, Lu J, Zhang LY, Lin XZ, Chen KM, Chen ZJ, Liu FJ, Yan FH, Teng GJ, Mao AW. 2015. Biological effects of low-dose-rate irradiation of pancreatic carcinoma cells in vitro using 125I seeds. WJG. 21:2336–2342.
   PubMed Web of Science ®Google Scholar
• Williamson JF, Brenner DJ. 2008. Physics and biology of brachytherapy. In: Halperin EC, Perez CABL, editors. Perez and Brady’s: Principles and practice of radiation oncology. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; pp. 423–475.
   Google Scholar
• Winterhalter-jadrić M, Causević A, Jadrić R, Corić J, Hasić S, Kiseljaković E. 2011. Education in clinical chemistry and laboratory medicine in various European countries. Education of medical biochemists in Bosnia and Herzegovina. Biochem Med (Zagreb). 1:12–14.
   Google Scholar
• Yamazaki H, Yoshida K, Yoshioka Y, Shimizutani K, Furukawa S, Koizumi M, Ogawa K. 2013. High dose rate brachytherapy for oral cancer. J Radiat Res. 54:1–17.
   PubMed Web of Science ®Google Scholar